More

    AI Integration Accelerates Drug Discovery with NVIDIA BioNeMo

    Revolutionizing Drug Discovery Through Advanced AI Integration.

    The integration work involves the use of the cloud-connected lab solution leader Artificial’s lab orchestration platform and the BioNeMo AI supplied by NVIDIA in pursuit of expediting drug discovery processes. It demonstrates how the integration of AI undoubtedly has a substantial impact on drug discovery when it comes to the automation of molecular screening workflows.

    Another Blockbuster: Molecular Screen Automation

    NVIDIA BioNeMo

    Developed for the proof-of-concept of the main protease of SARS-CoV-2 that is crucial to the viral replication mechanism and considered a major target for COVID-19 therapy. The automation process aims to accelerate virtual screening and drug discovery. Moreover, this happens by letting BioNeMo’s AI program spit out candidate compounds purely on an automated basis. The proof-of-concept is another example to demonstrate that AI makes these things go lightning fast, until the day of clinical trials.

    Streamlining Molecular Screening

    Their platform provides flexibility for integrating instruments, devices, personnel, and data systems in the lab environment. The openness and adaptability are achieved by leveraging an API library and adapter modules. That can extend the BioNeMo’s AI functionalities for the ongoing process. In the long term, this enhances not just molecular screening but the whole essence by making things more efficient in general.

    AI integration with Nvidia Bionemo

    Commitment to Security and Compliance

    Artificial has made a big step in obtaining ISO 27001 and SOC 2 certifications, reiterating its commitment to data security and compliance. Such accreditations attest to a comprehensive framework that ensures the safeguarding of data. While at the same time mitigating security risks, and hence clients can be assured when using their services.

    Looking Ahead

    Artificial’s lab collaboration with the advances of BioNeMo AI from NVIDIA brings hope to the future of drug discovery. Additionally, this collaboration increases emphasis and prudent action toward embracing the advanced technology. The combination of AI and lab processes improves effectiveness and creates avenues for innovation in the pharmaceutical field. Which have been unexplored for the longest time.

    If you want to read about NVIDIA Jetson- The Ultimate Game-Changer for AI and Robotics click here.

    Stay Ahead in AI

    Get the daily email from Aadhunik AI that makes understanding the future of technology easy and engaging. Join our mailing list to receive AI news, insights, and guides straight to your inbox, for free.

    Latest stories

    You may also like

    Zomato Launches Nugget AI to Automate Customer Support

    Zomato Enters the AI Arena with Nugget Zomato introduces its own an AI startup Nugget. Having customer support which...

    Stay Ahead in AI

    Get the daily email from Aadhunik AI that makes understanding the future of technology easy and engaging. Join our mailing list to receive AI news, insights, and guides straight to your inbox, for free.